Fundraising FoxKPI Therapeutics
Seattle, US · Founded 2013 · Delaware corporation
Find your way into KPI Therapeutics
Sign up to see every warm intro you have to KPI Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the KPI Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CL
Charles L. MagnessExecutive
ML
Magness L. CharlesExecutive
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 4 rounds · 2014–2016
▶$18KraisedDec 2016 · 1 investors · BiotechnologyRule 506(b)
▶$18KraisedDec 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shawn IadonatoDirector
- James G. W. ReedDirector
- Ray BartoszekDirector
- Craig PhilipsExecutive Officer
- Paul SylvesterDirector
- Charles L. MagnessExecutive Officer, Director
- Steven MitchelDirector
- Don MerlinoDirector
- Thomas E HornishExecutive Officer
- Offering amount
- $3M
- Amount sold
- $18K
- Minimum investment
- $50K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$50.5KraisedFeb 2016 · 1 investors · BiotechnologyRule 506(b)
▶$50.5KraisedFeb 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Don MerlinoDirector
- James G. W. ReedDirector
- Craig PhilipsExecutive Officer
- Blake IlstrupExecutive Officer
- Charles L. MagnessExecutive Officer, Director
- Paul SylvesterDirector
- Offering amount
- $7.5M
- Amount sold
- $50.5K
- Minimum investment
- $50K
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$27KraisedMay 2015 · 2 investors · BiotechnologyRule 506(b)
▶$27KraisedMay 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles L. MagnessExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $27K
- Minimum investment
- $10K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.6MraisedMay 2014 · 43 investors · BiotechnologyRule 506(b)
▶$1.6MraisedMay 2014 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Magness L. CharlesExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $1.6M
- Minimum investment
- $25K
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has KPI Therapeutics raised?
- KPI Therapeutics has disclosed $1.7M raised across 4 rounds.
- Where is KPI Therapeutics headquartered?
- KPI Therapeutics is headquartered in Seattle, US.